Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Dow
McKesson
Express Scripts
Harvard Business School

Last Updated: December 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for GLPG1205

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the drug development status for GLPG1205?

GLPG1205 is an investigational drug.

There have been 5 clinical trials for GLPG1205. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2014.

The most common disease conditions in clinical trials are Ulcer, Colitis, Ulcerative, and Colitis. The leading clinical trial sponsors are Galapagos NV and [disabled in preview].

There are two US patents protecting this investigational drug and thirty-nine international patents.

Recent Clinical Trials for GLPG1205
TitleSponsorPhase
A Clinical Study to Test How Effective and Safe GLPG1205 is for Patients With Idiopathic Pulmonary Fibrosis (IPF)Galapagos NVPhase 2
A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male SubjectsGalapagos NVPhase 1
Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative ColitisGalapagos NVPhase 2

See all GLPG1205 clinical trials

Clinical Trial Summary for GLPG1205

Top disease conditions for GLPG1205
Top clinical trial sponsors for GLPG1205

See all GLPG1205 clinical trials

US Patents for GLPG1205

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GLPG1205   Start Trial Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders Galapagos NV (Mechelen, BE)   Start Trial
GLPG1205   Start Trial Dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders GALAPAGOS NV (Mechelen, BE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
AstraZeneca
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.